Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors.
Saved in:
| Title: | Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors. |
|---|---|
| Authors: | Zhu, Hong-Fei1 (AUTHOR), Feng, Jin-Kai1 (AUTHOR), Xiang, Yan-Jun1,2 (AUTHOR), Wang, Kang1 (AUTHOR), Zhou, Li-Ping1 (AUTHOR), Liu, Zong-Han1 (AUTHOR), Cheng, Yu-Qiang1 (AUTHOR), Shi, Jie1 (AUTHOR), Guo, Wei-Xing1 (AUTHOR), Cheng, Shu-Qun1,3 (AUTHOR) chengshuqun@aliyun.com |
| Source: | BMC Cancer. 6/15/2023, Vol. 23 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
